Cargando…
Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
Metabolic rewiring in glioblastoma (GBM) is linked to intra- and extracellular pH regulation. In this study, we sought to characterize the role of melatonin on intracellular pH modulation and metabolic consequences to identify the mechanisms of action underlying melatonin oncostatic effects on GBM t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654239/ https://www.ncbi.nlm.nih.gov/pubmed/36359862 http://dx.doi.org/10.3390/cells11213467 |
_version_ | 1784828880873324544 |
---|---|
author | Fernandez-Gil, Beatriz I. Otamendi-Lopez, Andrea Bechtle, Alexandra Vazquez-Ramos, Carla A. Qosja, Neda Suarez-Meade, Paola Sarabia-Estrada, Rachel Jentoft, Mark E. Guerrero-Cázares, Hugo Escames, Germaine Schiapparelli, Paula Quiñones-Hinojosa, Alfredo |
author_facet | Fernandez-Gil, Beatriz I. Otamendi-Lopez, Andrea Bechtle, Alexandra Vazquez-Ramos, Carla A. Qosja, Neda Suarez-Meade, Paola Sarabia-Estrada, Rachel Jentoft, Mark E. Guerrero-Cázares, Hugo Escames, Germaine Schiapparelli, Paula Quiñones-Hinojosa, Alfredo |
author_sort | Fernandez-Gil, Beatriz I. |
collection | PubMed |
description | Metabolic rewiring in glioblastoma (GBM) is linked to intra- and extracellular pH regulation. In this study, we sought to characterize the role of melatonin on intracellular pH modulation and metabolic consequences to identify the mechanisms of action underlying melatonin oncostatic effects on GBM tumor initiating cells. GBM tumor initiating cells were treated at different times with melatonin (1.5 and 3.0 mM). We analyzed melatonin’s functional effects on GBM proliferation, cell cycle, viability, stemness, and chemo-radiosensitivity. We then assessed the effects of melatonin on GBM metabolism by analyzing the mitochondrial and glycolytic parameters. We also measured the intracellular and extracellular pH. Finally, we tested the effects of melatonin on a mouse subcutaneous xenograft model. We found that melatonin downregulated LDHA and MCT4, decreasing lactate production and inducing a decrease in intracellular pH that was associated with an increase in ROS and ATP depletion. These changes blocked cell cycle progression and induced cellular death and we observed similar results in vivo. Melatonin’s cytotoxic effects on GBM were due, at least in part, to intracellular pH modulation, which has emerged as a newly identified mechanism, providing new insights into the oncostatic effect of melatonin on GBM. |
format | Online Article Text |
id | pubmed-9654239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96542392022-11-15 Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma Fernandez-Gil, Beatriz I. Otamendi-Lopez, Andrea Bechtle, Alexandra Vazquez-Ramos, Carla A. Qosja, Neda Suarez-Meade, Paola Sarabia-Estrada, Rachel Jentoft, Mark E. Guerrero-Cázares, Hugo Escames, Germaine Schiapparelli, Paula Quiñones-Hinojosa, Alfredo Cells Article Metabolic rewiring in glioblastoma (GBM) is linked to intra- and extracellular pH regulation. In this study, we sought to characterize the role of melatonin on intracellular pH modulation and metabolic consequences to identify the mechanisms of action underlying melatonin oncostatic effects on GBM tumor initiating cells. GBM tumor initiating cells were treated at different times with melatonin (1.5 and 3.0 mM). We analyzed melatonin’s functional effects on GBM proliferation, cell cycle, viability, stemness, and chemo-radiosensitivity. We then assessed the effects of melatonin on GBM metabolism by analyzing the mitochondrial and glycolytic parameters. We also measured the intracellular and extracellular pH. Finally, we tested the effects of melatonin on a mouse subcutaneous xenograft model. We found that melatonin downregulated LDHA and MCT4, decreasing lactate production and inducing a decrease in intracellular pH that was associated with an increase in ROS and ATP depletion. These changes blocked cell cycle progression and induced cellular death and we observed similar results in vivo. Melatonin’s cytotoxic effects on GBM were due, at least in part, to intracellular pH modulation, which has emerged as a newly identified mechanism, providing new insights into the oncostatic effect of melatonin on GBM. MDPI 2022-11-02 /pmc/articles/PMC9654239/ /pubmed/36359862 http://dx.doi.org/10.3390/cells11213467 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fernandez-Gil, Beatriz I. Otamendi-Lopez, Andrea Bechtle, Alexandra Vazquez-Ramos, Carla A. Qosja, Neda Suarez-Meade, Paola Sarabia-Estrada, Rachel Jentoft, Mark E. Guerrero-Cázares, Hugo Escames, Germaine Schiapparelli, Paula Quiñones-Hinojosa, Alfredo Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title | Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title_full | Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title_fullStr | Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title_full_unstemmed | Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title_short | Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma |
title_sort | melatonin treatment triggers metabolic and intracellular ph imbalance in glioblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654239/ https://www.ncbi.nlm.nih.gov/pubmed/36359862 http://dx.doi.org/10.3390/cells11213467 |
work_keys_str_mv | AT fernandezgilbeatrizi melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT otamendilopezandrea melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT bechtlealexandra melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT vazquezramoscarlaa melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT qosjaneda melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT suarezmeadepaola melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT sarabiaestradarachel melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT jentoftmarke melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT guerrerocazareshugo melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT escamesgermaine melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT schiapparellipaula melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma AT quinoneshinojosaalfredo melatonintreatmenttriggersmetabolicandintracellularphimbalanceinglioblastoma |